Cas no 223-22-3 (Quinoxalino[2,3-a]phenazine(8CI,9CI))

Quinoxalino[2,3-a]phenazine(8CI,9CI) structure
223-22-3 structure
Product Name:Quinoxalino[2,3-a]phenazine(8CI,9CI)
CAS No:223-22-3
MF:C18H10N4
MW:282.298802852631
CID:289882
PubChem ID:12486184
Update Time:2025-04-19

Quinoxalino[2,3-a]phenazine(8CI,9CI) Chemical and Physical Properties

Names and Identifiers

    • 5,8,13,14-Tetraazapentaphene
    • quinoxalino[2,3-a]phenazine
    • Quinoxalino[2,3-a]phenazine(8CI,9CI)
    • DTXSID40500039
    • 223-22-3
    • SCHEMBL4654883
    • AKOS015997037
    • Inchi: 1S/C18H10N4/c1-3-7-13-11(5-1)19-15-9-10-16-18(17(15)21-13)22-14-8-4-2-6-12(14)20-16/h1-10H
    • InChI Key: LHKBZFGMFKIGKJ-UHFFFAOYSA-N
    • SMILES: N1C2C=CC=CC=2N=C2C=CC3C(C=12)=NC1C=CC=CC=1N=3

Computed Properties

  • Exact Mass: 282.0907
  • Monoisotopic Mass: 282.090546336g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 22
  • Rotatable Bond Count: 0
  • Complexity: 376
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 3
  • Topological Polar Surface Area: 51.6?2

Experimental Properties

  • PSA: 51.56

Quinoxalino[2,3-a]phenazine(8CI,9CI) Related Literature

Recommended suppliers
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd
Tiancheng Chemical (Jiangsu) Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Henan Dongyan Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Henan Dongyan Pharmaceutical Co., Ltd
Hangzhou Cedareal Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hangzhou Cedareal Technology Co., Ltd.
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Hongxiang Biomedical Technology Co., Ltd.